Indapta Therapeutics's last reported valuation, May 2023. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Indapta Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Indapta Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Later Stage VC | $50.8M | ▮ | ▮ |
| Dec 2024 | Later Stage VC | $22.5M | ▮ | ▮ |
| May 2023 | Later Stage VC (Series A) | $80.0M | ▮ | ▮ |
| Jan 2022 | Early Stage VC | $33.6M | ▮ | ▮ |
Membership and data by Private Market View
Indapta Therapeutics valuation
Indapta Therapeutics's last reported valuation was $90 million in May 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Indapta Therapeutics raised?
Indapta Therapeutics has raised $162 million across 4 recorded rounds since 2022. The largest was an $80 million Series A in May 2023; the most recent was a $50.8 million later-stage round in Sep 2025.
Indapta Therapeutics has filed 1 Form D with the SEC, most recently in Feb 2022 ($33.6 million sold to 37 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Sydnexis ($90 million), Hyku Biosciences ($85 million) and Linnaeus Therapeutics ($83.1 million).
How Indapta Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Indapta Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Indapta Therapeutics
- What is Indapta Therapeutics worth?
- Indapta Therapeutics is valued at $90.0M as of Oct 2026. Indapta Therapeutics's last reported valuation, May 2023. Nothing priced has surfaced since.
- How much has Indapta Therapeutics raised?
- Indapta Therapeutics has raised $162.3M in total funding across 4 recorded rounds.
- When did Indapta Therapeutics last raise?
- Indapta Therapeutics last raised in Sep 2025 (Later Stage VC), raising $50.8M.